Media 280723

CTO Mr Craig Weller said on Aqua Phase studies revealing the absorption of CBD as more than 4 times greater than CBD in oil:
Bod has been sweating on the PK study for months. It needed to show improved bioavailability of 30% for the deal to proceed, it exceeded by a factor of 10, what this means is that if we ingest 100mg of CBD in oil, we will normally absorb 6-8% of the dose. With Aqua Phase, the CBD absorption is 32% This means we can either get a better response to the CBD or otherwise we can reduce the Aqua Phase dose – giving potentially less side effects and providing CBD raw material savings.
Bod Australia Scores US CBD Product Certification
23 Aug 2022
Published by: Hemp Gazette
Company news: Bod; Neurotech International; Emyria; Creso Pharma
23 Aug 2022
Published by: Cannabiz
Logging record growth in FY22, are investors overlooking Hydration Pharmaceuticals Company?
22 Aug 2022
Published by: Market Index
ASX Health Stocks: Big announcements as Invex and Antisense jump over 20pc this morning
19 Aug 2022
Published by: Stockhead
Medicinal cannabis player Bod Australia boosts US certification credentials
19 Aug 2022
Published by: Market Index
Awarded US Hemp Authority certificate for CBD products
19 Aug 2022
Published by: Next Investors
Bod Australia (ASX:BOD) awarded US Hemp Authority certificate for CBD extrac
19 Aug 2022
Published by: The Market Herald
Company news: ANTG; MGC Pharma; Medlab Clinical; Bod; Creso Pharma; InhaleRx; Incannex
04 Aug 2022
Published by: Cannabiz
Quarterly report - advancing multiple clinical trials
28 Jul 2022
Published by: Next Investors
Nursing body backs campaign to boost medicinal cannabis education
20 Jul 2022
Published by: Cannabiz